OLIVE HEALTH OIL · SPANISH DERMOCOSMETIC CARE

THE OHO+ SCIENCE LIBRARY

Nature is the beginning. Science asks why.

Eight research notes from the supplied papers: study designs, findings, relevance and limitations.

These studies concern ingredients or specific research formulations. They are not clinical trials of the finished OHO+ products in this shop.

RESEARCH NOTE / 0147patientsHuman pilot study · 2019

Scientific research about the ingredient

Oleocanthal & inflammation

What was studied?: 47 patients after photodynamic therapy; two sequential treatment groups (24 control, 23 oleocanthal).
What happened?: At 48 hours, the oleocanthal-enriched formulation group showed greater reduction in skin redness.
Why it matters: A signal worth studying further for this olive-oil phenolic compound.

Small, non-randomised pilot in a specific clinical setting; not a trial of the OHO+ products shown here.

Segura Palacios et al. · Complementary Therapies in Medicine, 42 (2019)Read the study

RESEARCH NOTE / 02COX1 & 2 enzymesLaboratory research · 2005

Scientific research about the ingredient

Why oleocanthal is interesting

What was studied?: Oleocanthal’s activity against COX-1 and COX-2 enzymes in laboratory assays.
What happened?: Dose-dependent inhibition of enzymes also targeted by ibuprofen.
Why it matters: Helps explain scientific interest in olive-oil phenolics and inflammatory pathways.

Laboratory findings do not make OHO+ skincare an alternative to ibuprofen or any medicine.

Beauchamp et al. · Nature, 437 (2005)Read the study

RESEARCH NOTE / 03EVOOphenolic compoundsScientific review · 2012

Scientific research about the ingredient

EVOO polyphenols

What was studied?: Research on phenolic compounds in extra-virgin olive oil across different study types.
What happened?: Reports antioxidant, anti-inflammatory and antimicrobial activities in the reviewed research.
Why it matters: Context for understanding the compounds within olive oil.

A review of ingredient research, not evidence that a finished OHO+ cosmetic treats a condition.

Cicerale, Lucas & Keast · Current Opinion in Biotechnology, 23 (2012)Read the study

RESEARCH NOTE / 04Nrf2and NF-κB pathwaysMechanistic review · 2020

Scientific research about the ingredient

Polyphenols, oxidative stress & cell signalling

What was studied?: A review of cell, animal and human research on how EVOO phenolics interact with Nrf2 and NF-κB, two pathways involved in antioxidant defence and inflammation.
What happened?: The reviewed experiments describe activation of cellular antioxidant responses and reduced pro-inflammatory signalling, particularly for hydroxytyrosol and tyrosol.
Why it matters: Explains mechanisms scientists investigate when studying olive-oil phenolics.

Much of the evidence concerns experimental models or dietary exposure. It does not establish anti-aging results, skin penetration or efficacy for an OHO+ cream.

Serreli & Deiana · Cells 9(2), 478 (2020)Read the study

RESEARCH NOTE / 05Lipidsand minor componentsNarrative review · 2009

Scientific research about the ingredient

Olive oil composition & skin care

What was studied?: The composition of virgin olive oil, its nutritional role and its potential as a raw material in cosmetic dermatology.
What happened?: Discusses fatty acids and smaller fractions containing phenolics, tocopherols and squalene. Their amounts vary with olive variety, harvest and production.
Why it matters: Gives background for the oil ingredient used in a formulated cosmetic.

This is not a controlled trial of the six products, a measurement of their phenolic content or proof of sun protection. Dietary findings cannot be directly applied to topical care.

Viola & Viola · Clinics in Dermatology 27, 159–165 (2009)Read the study

RESEARCH NOTE / 06In vitroand animal modelsPreclinical research review · 2021

Scientific research about the ingredient

Phenolic compounds & wound-healing research

What was studied?: Cell and animal studies of phenolic compounds found in several plants, including compounds also present in olive oil.
What happened?: Reports effects on inflammatory and oxidative processes, microbial activity and tissue-repair mechanisms in experimental models. The authors call for human studies.
Why it matters: Identifies questions for future research rather than a proven cosmetic use.

The compounds were not always sourced from olive oil. This is not evidence to apply OHO+ products to wounds; Repairing Forte must not be used on open wounds.

Melguizo-Rodríguez et al. · Foods 10(7), 1642 (2021)Read the study

RESEARCH NOTE / 0734enrolled · 30 analysedSmall randomised clinical trial · 2015

Scientific research about the ingredient

Olive oil in a specialised diabetic-foot study

What was studied?: Adults with type 2 diabetes and grade 1 or 2 foot ulcers. Olive oil plus routine clinical care was compared with routine care alone for four weeks; 15 people per group completed follow-up.
What happened?: Complete healing was reported in 11 of 15 participants receiving oil plus care (73.3%) versus 2 of 15 with care alone (13.3%). The study also reported improvements in ulcer area and depth.
Why it matters: A clinical signal in a specific patient group that needs larger confirmatory studies.

Small, single-centre study with four losses to follow-up; not an OHO+ trial. This does not support treating diabetic ulcers with retail skincare. Foot ulcers require professional medical care.

Nasiri et al. · Journal of Diabetes & Metabolic Disorders 14, 38 (2015)Read the study

RESEARCH NOTE / 0832participants · no control groupUncontrolled before/after study · 2021

Scientific research about the ingredient

EVOO & atopic dermatitis: preliminary observations

What was studied?: A single group of 32 participants assessed for dermatitis severity before and after an extra-virgin olive oil intervention.
What happened?: Before the intervention, 75% were classified as severe. Afterwards, 50% were classified as mild and 50% as moderate.
Why it matters: An observation that can help frame research questions; it cannot show that the oil caused the change.

No comparison group or randomisation; natural fluctuation and other factors cannot be excluded. It does not prove that OHO+ treats eczema or establish safety for babies.

Darwati, Sholikha & Muthoharoh · Jurnal MIDPRO 13(1), 140–146 (2021)Read the study